News Infinity Pharmaceuticals, Inc.

Stocks

INFI.Q

US45665G3039

Environmental Services & Equipment

End-of-day quote OTC Markets 2026-08-21			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

24-03-25	Infinity Pharmaceuticals, Inc. Went Out of Business	CI
24-03-06	Revised Liquidation Plan Approved for Infinity Pharmaceuticals, Inc.	CI

All News

Mentions Relevance

24-03-25	Infinity Pharmaceuticals, Inc. Went Out of Business	CI
24-03-06	Revised Liquidation Plan Approved for Infinity Pharmaceuticals, Inc.	CI
24-02-21	Motion for Di Minimis Assets Sale Approved for Infinity Pharmaceuticals, Inc.	CI
24-02-14	An unknown healthcare investment firm acquired Substantially all of the assets of Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q).	CI
24-02-12	First Motion for Exclusivity Period Extension Approved For Infinity Pharmaceuticals, Inc.	CI
24-02-01	Disclosure Statement Approved on Interim Basis for Infinity Pharmaceuticals, Inc.	CI
24-01-25	First Motion for Exclusivity Period Extension Filed by Infinity Pharmaceuticals, Inc.	CI
24-01-10	Joint Liquidation Plan and Disclsoure Statement Filed by Infinity Pharmaceuticals, Inc.	CI
24-01-07	Motion for Asset Sale Approved for Infinity Pharmaceuticals, Inc.	CI
23-10-23	Bidding Procedure Approved for Infinity Pharmaceuticals, Inc.	CI
23-10-02	Motion for Joint Administration Approved for Infinity Pharmaceuticals, Inc.	CI
23-09-29	Infinity Pharmaceuticals : Bankruptcy - Form 8-K	PU
23-09-29	Infinity Pharmaceuticals, Inc. Announces Resignation of Adelene Perkins from the Board	CI
23-09-29	Motion for Asset Sale Filed by Infinity Pharmaceuticals, Inc.	CI
23-09-29	Motion for Joint Administration Filed by Infinity Pharmaceuticals, Inc.	CI
23-09-29	Infinity Pharmaceuticals, Inc. Filed for Bankruptcy	CI
23-09-18	Infinity Pharmaceuticals, Inc.(OTCPK:INFI) dropped from S&P TMI Index	CI
23-09-13	Infinity Pharmaceuticals, Inc.(OTCPK:INFI) dropped from NASDAQ Composite Index	CI
23-09-01	Infinity Pharmaceuticals, Inc. Announces Resignation of Robert Ilaria, Jr., M.D., as Chief Medical Officer	CI
23-09-01	Infinity Pharmaceuticals, Inc. Announces Chief Executive Officer Changes	CI
23-08-18	INFINITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm	BU
23-08-10	Infinity Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-07-25	Infinity Pharmaceuticals, Inc. Announces Resignation of Samuel Agresta, Sujay R. Kango and Brian Schwartz from Board	CI
23-07-25	Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan	BU
23-07-24	Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma	BU